Unknown

Dataset Information

ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma.


ABSTRACT:

Background

Although ALYREF has been demonstrated to have a role in a number of malignancies, its role in hepatocellular carcinoma (HCC) has received little attention. Our objective was to research at the prognostic value, biological role and relevance of ALYREF to the immune system in HCC.

Methods

The expression of ALYREF and its relationship with clinical parameters of HCC patients were analyzed by liver cancer cohort (LIHC) of The Cancer Genome Atlas. The expression and prognosis were verified by immunohistochemistry experiments. Gene transfection, CCK-8, scratch healing, transwell invasion and flow cytometry were used to assess the molecular function of ALYREF in vitro. The TIMER and TISIDB online data portals were used to assess the relevance of ALYREF to immunization. S

SUBMITTER: Wang ZZ 

PROVIDER: S-EPMC9079359 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature